Formulated Palmitoylethanolamide Supplementation Improves Parameters of Cognitive Function and BDNF Levels in Young, Healthy Adults: A Randomised Cross-Over Trial
Nutrients · 2024
DOI: 10.3390/nu16040489 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Nadia Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Nutraceuticals, University of Westminster, London W1W6 UW, UK. Hauptthemen laut MEDLINE: Brain-Derived Neurotrophic Factor, Cognition, Amides, Ethanolamines. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gencor, Knowledge Exchange funding from Gencor Pacific Ltd..
Abstract (Originalsprache)
Background
Palmitoylethanolamide (PEA) is an endocannabinoid-like lipid mediator which is naturally produced in the body and found in certain foods. The aim of this study was to assess the effect of a bioavailable formulated form of PEA (Levagen+®) on serum BDNF levels and parameters of cognitive function in healthy adults.
Methods
A randomised double-blinded placebo-controlled cross-over trial was implemented to measure the effects of a 6-week 700 mg/day course of formulated PEA supplementation versus a placebo.
Participants
(n = 39) completed pre- and post-assessments of a lab-based cognitive test. Serum samples were collected to measure BDNF concentrations using an immunoassay.
Results
A significant increase in serum BDNF levels was found following PEA supplementation compared with the placebo (p = 0. 0057, d = 0.62). The cognition test battery demonstrated improved memory with PEA supplementation through better first success (p = 0.142, d = 0.54) and fewer errors (p = 0.0287; d = −0.47) on the Paired Associates Learning test.
Conclusion
This was the first study to report a direct beneficial effect of Levagen+® PEA supplementation on memory improvement as well as corresponding increases in circulating neurotrophic marker levels. This suggests that formulated PEA holds promise as an innovative and practical intervention for cognitive health enhancement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Nutraceuticals, University of Westminster, London W1W6 UW, UK.
- Centre for Health and Life Sciences (CHLS), Coventry University, Coventry CV1 5FB, UK.
- Cambridge Centre for Sport and Exercise Sciences, Anglia Ruskin University, Cambridge CB1 1PT, UK.
ORCID-Profile: Derek Renshaw, Sanjoy K Deb
Förderung
- Gencor
- Knowledge Exchange funding from Gencor Pacific Ltd.
Zitieren
APA
Kim, N., Parolin, B., Renshaw, D., Deb, S. K., & Zariwala, M. G. (2024). Formulated Palmitoylethanolamide Supplementation Improves Parameters of Cognitive Function and BDNF Levels in Young, Healthy Adults: A Randomised Cross-Over Trial. Nutrients. https://doi.org/10.3390/nu16040489
Vancouver
Kim N, Parolin B, Renshaw D, Deb SK, Zariwala MG. Formulated Palmitoylethanolamide Supplementation Improves Parameters of Cognitive Function and BDNF Levels in Young, Healthy Adults: A Randomised Cross-Over Trial. Nutrients. 2024. doi:10.3390/nu16040489
BibTeX
@article{Kim2024,
author = {Kim, Nadia and Parolin, Brenda and Renshaw, Derek and Deb, Sanjoy K and Zariwala, Mohammed Gulrez},
title = {Formulated Palmitoylethanolamide Supplementation Improves Parameters of Cognitive Function and BDNF Levels in Young, Healthy Adults: A Randomised Cross-Over Trial},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16040489}
}
EUVIMED